SOF/VEL and Resistance-associated Substitutions in HCV GT3 SOF/VEL and Resistance-associated Substitutions in HCV GT3

Does the presence of resistance-associated substitutions impact the efficacy of therapy with sofosbuvir/velpatasvir with or without ribavirin in patients with HCV genotype 3?Alimentary Pharmacology & Therapeutics
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news